Boston, MA 09/17/2014 (wallstreetpr) –According to reports published in Wall Street Journal, Trian Fund Management LP, which is owned by well-known activist investor Nelson Peltz, has decided to introduce a campaign. The main objective of this campaign is nothing but to force the chemical company E I Du Pont De Nemours And Co (NYSE:DD) to break itself up. Trian Fund Management LP took this step after DD didn’t take any of its private calls even after trying for several times. The WSJ has also stated that Trian Fund Management is seeking support from other investors as well in order to dismantle DD completely.
What’s The Matter:
Tiran Fund Management LP wrote a letter to the board of directors of E I Du Pont De Nemours And Co (NYSE:DD) in which it proposed to form a public company made of various advanced and fast growing units. In the letter, the former suggested to include its nutrition and agriculture business in that public sector company. Apart from the nutrition and agriculture business, Tiran Fund Management LP also wanted to include other options as well that could generate strong cash flow over the coming years. In its defense, Trian Fund Management said that if executed, its plan could easily eliminate cost of $2 billion to $4 billion without any hassle. Other than cost cut, E I Du Pont De Nemours And Co (NYSE:DD)’s separated units would also be able to perform significantly as they would be better focused and motivated and also free from corporate red tape.
As per the reports, E I Du Pont De Nemours And Co (NYSE:DD) is already in the process of finishing all the formalities of closing one of its businesses named performance chemicals. It is very active in the production of Teflon and household paint. There are various rumors about the matter as there is no clarity from DD or Trian Fund Management LLP’s side. The management of both the companies denied commenting on this matter; hence, no further information was accessible.
This is Default Discalimer. Please update this from the Intrinio Plugin setting page